Advanced in Prostate Cancer

Dr. Jonathan A. Chatzkel

Hematology Oncology | Hematology | Oncology
Florida Clinical Practice Association Inc
2000 Sw Archer Rd, Uf Health Congenital Heart, 
Gainesville, FL 
Accepting New Patients
Offers Telehealth
Advanced in Prostate Cancer
Florida Clinical Practice Association Inc
2000 Sw Archer Rd, Uf Health Congenital Heart, 
Gainesville, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Jonathan Chatzkel is a Hematologist Oncology specialist and a Hematologist in Gainesville, Florida. Dr. Chatzkel is rated as an Advanced provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Renal Cell Carcinoma (RCC), Prostate Cancer, Familial Prostate Cancer, Nephrectomy, and Orchiectomy. Dr. Chatzkel is currently accepting new patients.

His clinical research consists of co-authoring 17 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles and participated in 2 clinical trials in the study of Prostate Cancer.

Specialties
Hematology Oncology
Hematology
Oncology
Licenses
Internal Medicine in FL
Hospital Affiliations
Uf Health Shands Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Florida Blue
  • EPO
  • PPO
Freedom Health
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MVP Health
  • EPO
  • PPO
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

FLORIDA CLINICAL PRACTICE ASSOCIATION INC
2000 Sw Archer Rd, Uf Health Congenital Heart, Gainesville, FL 32610
Other Locations
FLORIDA CLINICAL PRACTICE ASSOCIATION INC
2001 Sw 13th St, Gi Clinic At Endoscopy Cen, Gainesville, FL 32608
FLORIDA CLINICAL PRACTICE ASSOCIATION INC
1600 Sw Archer Rd, Suite 100371, Gainesville, FL 32610

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
Enrollment Status: Suspended
Publish Date: October 15, 2025
Intervention Type: Drug
Study Drugs: Atezolizumab, Tivozanib
Study Phase: Phase 1/Phase 2
Phase III Randomized Adjuvant Study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation
Phase III Randomized Adjuvant Study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation
Enrollment Status: Active_not_recruiting
Publish Date: October 09, 2025
Intervention Type: Other, Biological, Procedure
Study Drug: Pembrolizumab
Study Phase: Phase 3
PD-Inhibitor (Nivolumab) and Ipilimumab Followed by Nivolumab Vs. VEGF TKI Cabozantinib With Nivolumab: A Phase III Trial in Metastatic Untreated REnal Cell CancEr [PDIGREE]
PD-Inhibitor (Nivolumab) and Ipilimumab Followed by Nivolumab Vs. VEGF TKI Cabozantinib With Nivolumab: A Phase III Trial in Metastatic Untreated REnal Cell CancEr [PDIGREE]
Enrollment Status: Active_not_recruiting
Publish Date: September 22, 2025
Intervention Type: Other, Procedure, Drug, Biological
Study Drugs: Cabozantinib, Ipilimumab, Nivolumab
Study Phase: Phase 3
Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk With Radiation (PREDICT-RT*)
Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk With Radiation (PREDICT-RT*)
Enrollment Status: Active_not_recruiting
Publish Date: September 11, 2025
Intervention Type: Drug, Procedure, Other, Radiation
Study Drugs: Abiraterone acetate, Apalutamide, Bicalutamide, Buserelin, Degarelix, Flutamide, Goserelin, Histrelin, Leuprolide, Prednisone, Triptorelin
Study Phase: Phase 3
A Phase 3 RandOmized Study Comparing PERioperative Nivolumab vs. Observation in Patients With Renal Cell Carcinoma Undergoing Nephrectomy (PROSPER RCC)
A Phase 3 RandOmized Study Comparing PERioperative Nivolumab vs. Observation in Patients With Renal Cell Carcinoma Undergoing Nephrectomy (PROSPER RCC)
Enrollment Status: Active_not_recruiting
Publish Date: July 28, 2025
Intervention Type: Other, Biological, Procedure
Study Drug: Nivolumab
Study Phase: Phase 3
View 4 Less Clinical Trials

17 Total Publications

Near-complete resolution of tumour thrombus in a patient with advanced non-seminomatous germ cell tumour: a multidisciplinary approach without surgical intervention.
Near-complete resolution of tumour thrombus in a patient with advanced non-seminomatous germ cell tumour: a multidisciplinary approach without surgical intervention.
Journal: BMJ case reports
Published: July 05, 2025
Similar Doctors
Advanced in Prostate Cancer
Dr. William P. Peters
Hematology Oncology | Hematology | Oncology
Advanced in Prostate Cancer
Dr. William P. Peters
Hematology Oncology | Hematology | Oncology

Ackerman Cancer Center PA

10881 San Jose Blvd, 
Jacksonville, FL 
 (57.1 miles away)
904-260-3022
Languages Spoken:
English
See accepted insurances
Accepting New Patients

William Peters is a Hematologist Oncology specialist and a Hematologist in Jacksonville, Florida. Dr. Peters is rated as an Advanced provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Colorectal Cancer, Familial Prostate Cancer, Prostate Cancer, and Familial Colorectal Cancer. Dr. Peters is currently accepting new patients.

Advanced in Prostate Cancer
Dr. Avani A. Changela
Hematology Oncology | Hematology | Oncology
Advanced in Prostate Cancer
Dr. Avani A. Changela
Hematology Oncology | Hematology | Oncology

Baptist MD Anderson Cancer Physicians Inc

14546 Old Saint Augustine Rd, Suite 100, 
Jacksonville, FL 
 (59.8 miles away)
904-202-7300
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Avani Changela is a Hematologist Oncology specialist and a Hematologist in Jacksonville, Florida. Dr. Changela is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. Her top areas of expertise are Familial Colorectal Cancer, Monoclonal Gammopathy of Undetermined Significance (MGUS), Colorectal Cancer, and Follicular Lymphoma. Dr. Changela is currently accepting new patients.

Advanced in Prostate Cancer
Dr. Dennie V. Jones
Oncology
Advanced in Prostate Cancer
Dr. Dennie V. Jones
Oncology

Florida Clinical Practice Association Inc

2001 Sw 13th St, 
Gainesville, FL 
 (0.7 miles away)
352-265-8990
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Dennie Jones is an Oncologist in Gainesville, Florida. Dr. Jones is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Small Cell Lung Cancer (SCLC), ALK-Positive Non-Small Cell Lung Cancer, Lung Adenocarcinoma, Squamous Cell Lung Carcinoma, and Tissue Biopsy. Dr. Jones is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Chatzkel's expertise for a condition
ConditionClose
      View All 9 Advanced Conditions
      View All 15 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile